REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (di/ S) Regulatory News (SPSC)

Share Price Information for Spectra (di/ S) (SPSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 260.00
Bid: 220.00
Ask: 300.00
Change: 0.00 (0.00%)
Spread: 80.00 (36.364%)
Open: 260.00
High: 260.00
Low: 260.00
Prev. Close: 260.00
SPSC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Share Options

28 Mar 2022 07:00

RNS Number : 1537G
Spectra Systems Corporation
28 March 2022
 

Spectra Systems Corporation("Spectra" or the "Company")

Grant of Share Options

Spectra Systems Corporation, a leader in machine-readable high speed banknote authentication, brand protection technologies and gaming security software announces that in accordance with the Company's 2007 Incentive Compensation Plan and the recommendation of the Compensation Committee, the Board granted options ("Options") over 531,000 shares of Common Stock ("Shares") to Corporate Officers and other employees of the Company.

Since the Company was admitted to trading on AIM on 25 July 2011, options issued over a total of 3,600,667 Shares remain outstanding, including this grant of Options, and 422,615 Shares have been issued as a result of option exercises. The aggregate total of 4,023,282 represents 8.9 percent of Spectra's current issued shares of common stock. Additionally, 5,403,649 pre-admittance options have expired since 25 July 2011.

The Options, which expire on 25 March 2032, have an exercise price of 150.50 pence per Share and vest over three years, one-third per year.

The grant of the Options is designed to align the interests of key employees of the Company with those of shareholders and to promote the retention of those individuals.

Details of the number of shares over which Options have been granted to Persons Discharging Management Responsibilities of the Company and their resultant interests are set out below:

Name

Title

New Options

Existing Options

Total Options

Total Shares

Nabil Lawandy

CEO

150,000

1,881,063

2,031,063

2,247,736

Brian McLain

CFO

120,000

212,000

332,000

38,000

 

Donald Stanford, Chairman of the Compensation Committee commented: "We believe that this grant of options, which accords with our policy as announced at the time of our IPO in 2011, provides an opportunity for our key employees to benefit from significantly growing the value of our company, thereby aligning their interests with shareholders." 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Enquiries:

Spectra Systems Corporation

 

Dr. Nabil Lawandy, Chief Executive Officer

Tel: +1 (0) 401 274 4700

 

 

WH Ireland Limited (Nominated Adviser and Broker)

 

Chris Fielding (Head of Corporate Finance)

Andrew de Andrade (Executive, Corporate Finance)

Tel: +44 (0) 20 7220 1650

 

 

Allenby Capital Limited (Joint Broker)

 

Nick Naylor/James Reeve (Corporate Finance)

Tel: +44 (0) 20 3328 5665

Amrit Nahal (Sales and Corporate Broking)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHMZGZFLNNGZZM
Date   Source Headline
22nd Jun 20172:18 pmRNSPosting of Annual Report and Accounts
18th May 20173:47 pmRNSExercise of Options
5th May 20172:01 pmRNSExercise of Options
13th Apr 201711:26 amRNSExercise of Options
30th Mar 20177:00 amRNSPreliminary Results
17th Mar 20177:00 amRNSAppointment of Chief Financial Officer
23rd Jan 20177:00 amRNSAppointment of Chief Financial Officer
4th Jan 20177:00 amRNSTrading Update
5th Dec 20167:00 amRNSResignation of Chief Financial Officer
1st Dec 20167:00 amRNSAnnual General Meeting Postponed
3rd Oct 20167:00 amRNSNew Five Year Contract with G7 Central Bank
21st Sep 20165:06 pmRNSHolding(s) in Company
19th Sep 20167:00 amRNSInterim Results for 6 Months ended 30 June 2016
7th Sep 20167:00 amRNSInterim Results Pre-announcement
24th Jun 20167:00 amRNSPosting of Annual Report and Accounts
31st May 20167:00 amRNSGrant of share options
25th May 20165:12 pmRNSHolding(s) in Company
5th May 20167:00 amRNSFirst TruBrand customer
18th Apr 20169:41 amRNSHolding(s) in Company
18th Apr 20167:00 amRNSPreliminary Results
16th Feb 20167:00 amRNSExpected grant of share options
8th Feb 20167:00 amRNSTrading update and expected grant of share options
29th Jan 20167:00 amRNS$3m Acquisition of Key Specialty Phosphour Assets
27th Jan 20164:01 pmRNSHolding(s) in Company
17th Dec 20154:34 pmRNSRemoval of Restrictions from Common Stock
30th Nov 20157:00 amRNSHolding(s) in Company
17th Nov 20157:00 amRNSAGM Postponement
4th Nov 20154:28 pmRNSHolding(s) in Company
4th Nov 20151:57 pmRNSRemoval of Restrictions from Common Stock
16th Oct 20159:53 amRNSRemoval of Restrictions from Common Stock
2nd Oct 20153:17 pmRNSNotice of AGM
10th Sep 20152:30 pmRNSHolding(s) in Company
1st Sep 20154:41 pmRNSSettlement of Common Shares
1st Sep 20157:03 amRNSInterim results for 6 months ended 30 June 2015
14th Aug 20152:42 pmRNSRemoval of Restrictions from Common Stock
14th Aug 20157:00 amRNSModified Covert Materials Supply Contract
3rd Jul 20157:00 amRNSHolding(s) in Company
2nd Jul 20157:00 amRNSContract Win
19th Jun 201511:17 amRNSPosting of Annual Report and Accounts
16th Jun 20154:06 pmRNSRemoval of Restrictions from Common Stock
19th May 20158:46 amRNSRemoval of Restrictions from Common Stock
18th May 20153:50 pmRNSHolding(s) in Company
22nd Apr 20157:31 amRNSPreliminary Results
2nd Apr 20153:05 pmRNSRemoval of Restrictions from Common Stock
19th Mar 20152:23 pmRNSRemoval of Restrictions from Common Stock
5th Mar 20158:40 amRNSHolding(s) in Company
10th Feb 20157:00 amRNSContract Win
3rd Feb 20158:02 amRNSHolding(s) in Company
23rd Dec 20144:35 pmRNSHolding(s) in Company
9th Dec 20147:00 amRNSNotice of Allowance from the US Patent Office

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.